Creating a National Infrastructure for Good Clinical Practice in Clinical Trials in Ukraine

被引:0
|
作者
Yurii I. Kundiiev
Peter N. Vitte
Vyctor G. Lyzogub
Alla Stepanenko
机构
[1] National Bioethics Committee of Ukraine,Clinical Trials Coordination and Control Board, State Pharmacological Center
[2] Information Centre on Bioethics,Institute for Occupational Health
[3] Ministry of Health,undefined
[4] Academy of Medical Sciences of Ukraine,undefined
关键词
Ethical Review; Good Clinical Practice; Medical Institution; Pharmaceutical Product; Bioethic Committee;
D O I
10.1007/BF03256732
中图分类号
学科分类号
摘要
This article examines the current Ukrainian approach to creating a national infrastructure for medicines advancement and human subjects protection through clinical trials based on good clinical practice (GCP). It explores the roles of the government, the healthcare society, ethics committees and industry in contributing to the development of a national infrastructure that contributes to national needs in health research as well as the global development of medicines.
引用
收藏
页码:355 / 358
页数:3
相关论文
共 50 条
  • [31] Adherence in clinical trials and in clinical practice
    Walsh, JC
    ANTIVIRAL THERAPY, 1999, 4 : 49 - 54
  • [32] Good clinical practice for radiology laboratories involved in bone disease clinical drug trials.
    Jones, DJ
    Blunt, BA
    vanKuijk, C
    Svensen, R
    Genant, HK
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : T636 - T636
  • [33] Rules for the conduct of clinical trials need revision, but ?good clinical practice? requires much more
    Salawu, A.
    Tannock, I. F.
    ANNALS OF ONCOLOGY, 2023, 34 (01) : 4 - 6
  • [34] GOOD CLINICAL-PRACTICE IN EUROPE - REGULATORY REQUIREMENTS FOR DRUG TRIALS
    HVIDBERG, EF
    PSYCHOPHARMACOLOGY, 1990, 100 (04) : B6 - B6
  • [35] Implementation of good clinical practice guidelines in vaccine trials in developing countries
    Acosta, Camilo J.
    Galindo, Claudia M.
    Ochiai, R. Leon
    Danovaro-Holliday, M. Carolina
    Laure-Page, Anne
    Thiem, Vu Dinh
    Jin, Yang
    Khan, Mohammad Imran
    Sahito, Shah Muhammad
    Bin Hamza, Hasan
    Park, Jin Kyoung
    Lee, Hyejon
    Bock, Hans
    Abu Elyazeed, Remon
    Albert, M. John
    Ascaso, Carlos
    Robles, Tonette Q.
    Ali, Mohammad
    Ngai, Philip
    Puri, Mahesh K.
    Koo, Young Mo
    Agtini, Magdarina D.
    Soeharno, Rooswanti
    Dong Bai-qing
    Kohl, Daniele
    Xu, Zhi-Yi
    Ivanoff, Bernard
    Jodara, Luis
    Pang, Tikki
    Bhutta, Zultiqar
    Clemens, John D.
    VACCINE, 2007, 25 (15) : 2852 - 2857
  • [36] Clinical trials: Are they a good buy?
    Bennett, CL
    Adams, JR
    Knox, KS
    Kelahan, AM
    Silver, SM
    Bailes, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) : 4330 - 4339
  • [37] Putting the "good" into Good Clinical Practice
    Symons, Tanya
    Webb, Steve
    Zalcberg, John R.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (02) : 62 - +
  • [38] Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials
    Graf, N
    Göbel, U
    KLINISCHE PADIATRIE, 2004, 216 (03): : 129 - 131
  • [39] A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network
    Pon, Jeng-Jong
    Nahm, Meredith
    Wakim, Paul
    Cushing, Carol
    Poole, Lori
    Tai, Betty
    Pieper, Carl F.
    CLINICAL TRIALS, 2009, 6 (01) : 67 - 75
  • [40] Person-Centric Clinical Trials: An Opportunity for the Good Clinical Practice (GCP)-Practice-Based Research Network
    Curro, Frederick A.
    Robbins, Dennis A.
    Millenson, Michael L.
    Fox, Chester H.
    Naftolin, Frederick
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (10): : 1091 - 1094